Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet [Klor-Con]
RxNorm concept 1801299, branded drug (sbd). Prescribable name: Klor-Con M10 10 MEQ Extended Release Oral Tablet.
- RxCUI
- 1801299
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1801299 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Klor-Con M10 10 MEQ Microencapsulated Extended Release Oral Tablet; Klor-Con M10 750 MG Microencapsulated Extended Release Oral Tablet; Microencapsulated K+ Chloride 10 MEQ Extended Release Oral Tablet [Klor-Con]; Microencapsulated Pot Chloride 10 MEQ Extended Release Oral Tablet [Klor-Con]
Related concepts
- potassium chloride 10 MEQ (SCDC, consists of)
- potassium chloride 10 MEQ [Klor-Con] (SBDC, consists of)
- Extended Release Oral Tablet (DF, has dose form)
- Klor-Con (BN, has ingredient)
- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet (SCD, tradename of)
Linked data
NDCs
- 00245531701
- 00245531710
- 00245531711
- 00245531789
- 00245531790
- 43353099060
- 43353099080
- 66758017001
- 66758017006
- 66758017010
- 66758017013
- 66758017092
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1801299 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1801299 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1801299. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.